Sirtex Medical Limited Is A Global Healthcare Company Focused On Developing And Distributing Medical Devices For Cancer Treatmentparticularly Inoperable Liver Cancerfounded In 1997 In Australiasirtex Has Expanded Its Operations To Include Offices And Production Facilities In The U S Germanyand Singaporethe Company Is Currently Owned By China Grand Pharmaceutical And Healthcare Holdings Ltdand Cdh Genetechltd The Primary Service Offered By Sirtex Is Selective Internal Radiation Therapysirt Which Uses Radioactive Microspheres To Deliver Targeted Radiation Directly To Liver Tumorsminimizing Damage To Surrounding Healthy Tissuesirtex S Flagship Product Is Sir Spheres Yttrium 90 Resin Microsphereswhich Are Injected Into Liver Tumors To Destroy Cancer Cells While Sparing Healthy Tissuethe Company Also Provides The Lava Liquid Embolic Systemsirtex Collaborates With Healthcare Providersincluding Oncologists And Radiologiststo Enhance Treatment Options For Patients With Inoperable Liver Cancerwith Around 1 000 Employeessirtex Is Dedicated To Improving Outcomes For Cancer Patients Worldwide
